Transforming commercial pharma with agentic AI
This newsletter focuses on the challenges and opportunities facing the pharmaceutical industry, particularly regarding cost pressures, patent expirations, and the growing demand for personalized medicine. It highlights Agentic AI as a key solution to these challenges, improving efficiency and personalization across various aspects of the pharma business.
-
Economic Pressures: Pharma is facing rising costs of raw materials, supply chain disruptions, and pressure to lower drug prices, all while dealing with patent cliffs.
-
Personalized Medicine Demand: There's an increasing demand for personalized services and targeted therapies, which are complex and expensive to produce.
-
Sales and Marketing Challenges: Reaching healthcare professionals is becoming more difficult, requiring personalized communication and relevant content, but MLR reviews are slowing down the process.
-
AI as a Solution: The newsletter promotes Agentic AI as a way to streamline operations, personalize interactions, and manage the growing complexity within the pharmaceutical industry.
-
The pharmaceutical industry could lose $300 billion in sales by 2030 due to patent expirations.
-
The cost to launch a new drug is increasing by 8% annually, reaching $4 billion in 2022.
-
Biopharma companies are reaching fewer healthcare professionals (45% in 2024, down from 60% in 2022), emphasizing the need for better engagement strategies.
-
AI is being explored for efficiencies in traditionally human roles, but the ethics of the technology are still being questioned.